Chemistry of Gene Silencing: the Mechanism of NAD+-dependent Deacetylation Reactions
Overview
Affiliations
The Sir2 enzyme family is responsible for a newly classified chemical reaction, NAD(+)-dependent protein deacetylation. New peptide substrates, the reaction mechanism, and the products of the acetyl transfer to NAD(+) are described for SIR2. The final products of SIR2 reactions are the deacetylated peptide and the 2' and 3' regioisomers of O-acetyl ADP ribose (AADPR), formed through an alpha-1'-acetyl ADP ribose intermediate and intramolecular transesterification reactions (2' --> 3'). The regioisomers, their anomeric forms, the interconversion rates, and the reaction equilibria were characterized by NMR, HPLC, 18O exchange, and MS methods. The mechanism of acetyl transfer to NAD(+) includes (1) ADP ribosylation of the peptide acyl oxygen to form a high-energy O-alkyl amidate intermediate, (2) attack of the 2'-OH group on the amidate to form a 1',2'-acyloxonium species, (3) hydrolysis to 2'-AADPR by the attack of water on the carbonyl carbon, and (4) an SIR2-independent transesterification equilibrating the 2'- and 3'-AADPRs. This mechanism is unprecedented in ADP-ribosyl transferase enzymology. The 2'- and 3'-AADPR products are candidate molecules for SIR2-initiated signaling pathways.
SIRT5: a potential target for discovering bioactive natural products.
Xie Y, Cai N, Liu X, He L, Ma Y, Yan C J Nat Med. 2025; .
PMID: 39979670 DOI: 10.1007/s11418-024-01871-6.
Hajra D, Rajmani R, Chaudhary A, Gupta S, Chakravortty D Elife. 2024; 13.
PMID: 39693143 PMC: 11655064. DOI: 10.7554/eLife.93125.
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.
Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z Theranostics. 2024; 14(17):6726-6767.
PMID: 39479446 PMC: 11519805. DOI: 10.7150/thno.100667.
Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity.
Shenk T, Kulp Iii J, Chiang L Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458938 PMC: 11510315. DOI: 10.3390/ph17101298.
Activation and inhibition of sirtuins: From bench to bedside.
Fiorentino F, Fabbrizi E, Mai A, Rotili D Med Res Rev. 2024; 45(2):484-560.
PMID: 39215785 PMC: 11796339. DOI: 10.1002/med.22076.